Milestone Pharmaceuticals Inc.
NASDAQ:MIST
Overview | Financials
Company Name | Milestone Pharmaceuticals Inc. |
Symbol | MIST |
Currency | USD |
Price | 1.97 |
Market Cap | 105,055,963 |
Dividend Yield | 0% |
52-week-range | 1.12 - 2.75 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joseph G. Oliveto M.B.A. |
Website | https://www.milestonepharma.com |
An error occurred while fetching data.
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD